A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion
Open Access
- 12 September 2026
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1) , 794
Abstract
Tumor-associated macrophages (TAMs) are key regulators of the tumor microenvironment, yet the functional specialization of TAM subsets in metastatic progression remains incompletely defined. Here, we characterized distinct TAM populations contributing to tumor-promoting mesothelial cell conversion in high-grade ovarian carcinoma using single-cell RNA sequencing of patient-derived macrophages from ascites (ascTAMs) and omental metastases (omTAMs). TAMs from these anatomical sites were clearly distinguishable by polarization states, with omTAMs exhibiting a mixed M1⁺/M2⁺ phenotype, in contrast to the M1 low /M2⁺ profile observed in ascTAMs. Transcriptomic analysis further revealed functional divergence of these subsets. Notably, omTAMs displayed gene signatures associated with mesothelial-to-mesenchymal transition (MMT), a critical process enabling tumor invasion across the peritoneal lining. Functionally, conditioned media from omTAMs, similar to that from classically activated M1 macrophages, induced MMT in primary mesothelial cells via TGFβ and ERK/p38 MAPK signaling pathways. This phenotypic transition enhanced transmesothelial tumor cell invasion. Proteomic analysis identified IL-1α as a key MMT-inducing factor secreted by pro-inflammatory macrophages. Mechanistically, IL-1α cooperates with TGFβ by activating an autocrine TGFβ/TGFBR1 feedback loop in mesothelial cells, thereby amplifying MMT. Consistent with these findings, IL1A expression was enriched in omTAM clusters across independent patient samples and was confirmed by immunohistochemical analysis of clinical samples. From a therapeutic perspective, our study identifies new avenues to counteract the mesothelial reprogramming driven by IL-1α⁺ TAMs, potentially impeding metastatic progression.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (416910386 GRK 2573)
- Deutsche Forschungsgemeinschaft (416910386 GRK 2573)
- Deutsche Forschungsgemeinschaft (416910386 GRK 2573)
- Deutsche Forschungsgemeinschaft (416910386 GRK 2573)
- Deutsche Forschungsgemeinschaft (416910386 GRK 2573)
- Deutsche Forschungsgemeinschaft (416910386 GRK 2573)
- Funding from the Universitätsklinikum Giessen und Marburg
- Senior professorship for Translational Oncology supported by the Anneliese Pohl Stiftung
This publication has 70 references indexed in Scilit:
- The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammationKidney International, 2013
- M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathwayLaboratory Investigation, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- The First Line of Intra-abdominal Metastatic Attack: Breaching the Mesothelial Cell LayerCancer Discovery, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.2009
- Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-κB/Snail1 pathwayDisease Models & Mechanisms, 2008
- Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interactionBritish Journal of Cancer, 2004
- Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial CellsNew England Journal of Medicine, 2003
- Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-β1-dependent mechanism in vitroAmerican Journal of Kidney Diseases, 2001